Title:
RECOMBINANT HUMAN CC 10 (rhCC10) FOR TREATMENT OF RESPIRATORY DISORDERS
Document Type and Number:
WIPO Patent Application WO2007109118
Kind Code:
A9
Abstract:
The present invention relates generally to the use of recombinant human CClO (rhCCIO), also known as recombinant human uteroglobin, for use as a therapeutic in the treatment of Respiratory Distress Syndrome (RDS), Bronchopulmonary dysplasia (BPD), chronic lung disease and/or pulmonary fibrosis, Asthma and Chronic Obstructive Pulmonary Disease (COPD). More particularly, the invention provides methods, including broadly the critical dosage ranges of rhCCIO, which may be administered to safely and effectively treat the aforementioned conditions. The invention further provides a composition useful in administering rhCCIO to humans.
Inventors:
PILON APRILE L (US)
Application Number:
PCT/US2007/006611
Publication Date:
December 27, 2007
Filing Date:
March 16, 2007
Export Citation:
Assignee:
CC 10 SWEDEN AB (US)
PILON APRILE L (US)
PILON APRILE L (US)
International Classes:
A61K38/00; C07K5/00; C07K7/00; C07K16/00; C07K17/00
Download PDF: